Depressive symptoms and levels of C-reactive protein: A population-based study

Social Psychiatry and Psychiatric Epidemiology

Volumn 44, Issue 3, 2009, Pages 217-222

  Pikhart, Hynek ^a   Hubacek, Jaroslav A ^b   Kubinova, Ruzena ^c   Nicholson, Amanda ^a   Peasey, Anne ^a   Capkova, Nada ^a   Poledne, Rudolf ^b   Bobak, Martin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

Author keywords

CRP; Depressive symptoms; Inflammation

Indexed keywords

AGED; ANXIETY DISORDERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; CZECH REPUBLIC; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 61349198816     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-008-0422-1     Document Type: Article

References (40)

1. Almeida OP, Norman P, Hankey GJ, Jamrozik K, Flicker L (2007) The association between C-reactive protein concentration and depression in later life is due to poor physical health: Results from the Health in Men Study (HIMS). Psychol Med 37:1775-1786
2. Ayuso-Mateos JL, Vazquez-Barquero JL, Dowrick C et al (2001) Depressive disorders in Europe: Prevalence figures from the ODIN study. Br J Psychiatry 179:308-316
3. Beekman AT, Deeg DJ, Van Limbeek J, Braam AW, De Vries MZ, Van Tilburg W (1997) Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): Results from a community-based sample of older subjects in The Netherlands. Psychol Med 27:231-235
4. Bierhaus A, Wolf J, Andrassy M et al (2003) A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci 100:1920-1925
5. Black PH, Garbutt LD (2002) Stress, inflammation and cardiovascular disease. J Psychosom Res 52:1-23
6. Blake GJ, Ridker P (2002) Inflammatory biomarkers and cardiovascular risk prediction. J Intern Med 252:283-294
7. Boekholdt S, Hack C, Sandhu M et al (2006) C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: The EPIC-Norfolk prospective population study 1993-2003. Atherosclerosis 187:415-422
8. Casas JP, Shah T, Cooper J et al (2006) Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 35:922-931
9. Danesh J, Wheeler JG, Hirschfield GM et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387-1397
10. Danner M, Kasl SV, Abramson JL, Vaccarino V (2003) Association between depression and elevated C-reactive protein. Psychosom Med 65:347-356
11. Douglas KM, Taylor AJ, O'Malley PG (2004) Relationship between depression and C-reactive protein in a screening population. Psychosom Med 66:679-683
12. Elovainio M, Keltikangas-Jarvinen L, Pulkki-Raback L et al (2006) Depressive symptoms and C-reactive protein: The Cardiovascular Risk in Young Finns Study. Psychol Med 36:797-805
13. Fountoulakis K, Iacovides A, Kleanthous S et al (2001) Reliability, validity and psychometric properties of the Greek translation of the Center for Epidemiological Studies-Depression (CES-D) Scale. BMC Psychiatry 1:3
14. Gump BB, Matthews KA, Eberly LE, Chang YF (2005) Depressive symptoms and mortality in men. Results from the multiple risk factors intervention trial. Stroke 36:98-102
15. Hemingway H, Marmot M (1999) Evidence based cardiology: Psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ 318:1460-1467
16. Hilton ME (1989) A comparison of a prospective diary and two summary recall techniques for recording alcohol consumption. Br J Addict 84:1085-1092
17. Kamphuis MH, Kalmijn S, Tijhuis MAR et al (2006) Depressive symptoms as risk factor of cardiovascular mortality in older European men: The Finland, Italy and Netherlands Elderly (FINE) study. Eur J Cardiovasc Prev Rehabil 13:199-206
18. Kessler RC, McGonagle KA, Zhao S et al (1994) Lifetime and 12-month prevalence of DSM-II-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51:8-19
19. Kop WJ (2003) The integration of cardiovascular behavioral medicine and psychoneuroimmunology: New developments based on converging research fields. Brain Behav Immun 17:233-237
20. Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J et al (2006) The association between C-reactive protein levels and depression: Results from the Northern Finland 1966 Birth Cohort Study. Biol Psychiatry 60:825-830
21. Lorant V, Deliege D, Eaton W, Robert A, Philippot P, Ansseau M (2003) Socioeconomic inequalities in depression: A meta-analysis. Am J Epidemiol 157:98-112
22. Lyness JM, Noel TK, Cox C, King DA, Conwell Y, Caine ED (1997) Screening for depression in elderly primary care patients. Arch Intern Med 157:449-454
23. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442
24. Meijer A, Zakay-Rones Z, Morag A (1988) Post-influenzal psychiatric disorder in adolescents. Acta Psychiatr Scand 78:176-181
25. Nicholson A, Kuper H, Hemingway H (2006) Depression as an aetiologic and prognostic factor in coronary heart disease: A meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 27:2763-2774
26. Osecká L (1999) Škála deprese CESD - psychometrická analýza. Akademie ved Ceské republiky-Psychologický ústav, Brno
27. Peasey A, Bobak M, Kubinova R et al (2006) Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: Rationale and design of the HAPIEE study. BMC Public Health 6:255
28. Radloff LS (1977) The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1:385-401
29. Rehm J (1998) Measuring quantity, frequency and volume drinking. Alcohol Clin Exp Res 22:4S-14S
30. Rehm J, Greenfield TK, Walsh G, Xie X, Robson L, Single E (1999) Assessment methods for alcohol consumption, prevalence of high risk drinking and harm: A sensitivity analysis. Int J Epidemiol 28:219-224
31. Ridker P, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
32. Roberts RE, Vernon SW (1983) The Center for Epidemiologic Studies Depression Scale: Its use in a community sample. Am J Psychiatry 140:41-46
33. Segerstrom S, Miller G (2004) Psychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol Bull 130:601-630
34. Sher L (2000) Psychological factors, immunity, and heart disease psychosomatics. Psychosomatics 41:372-373
35. Suarez EC (2004) C-reactive protein is associated with psychological risk factors of cardiovascular disease in apparently healthy adults. Psychosom Med 66:684-691
36. Toker S, Shirom A, Shapira I, Berliner S, Melamed S (2005) The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol 10:344-362
37. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ (2004) Global burden of depressive disorders in the year 2000. Br J Psychiatry 184:386-392
38. Vaccarino V, Johnson BD, Sheps DS et al (2007) Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: The National Heart, Lung, and Blood Instituteb - sponsored WISE Study. J Am Coll Cardiol 50:2044-2050
39. Watson D, Clark LA (1984) Negative affectivity; the disposition to experience aversive emotional states. Psychol Bull 96:465-490
40. Zorrilla EP, Luborsky L, McKay JR et al (2001) The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain Behav Immun 15:199-226